SEC Filing Summary for David Schmidt - Astrana Health, Inc.

David Schmidt, a director at Astrana Health, Inc. (ASTH), acquired 4,525 shares of restricted Common Stock on June 10, 2026. These shares were granted under the company's 2024 Equity Incentive Plan and will vest on the earlier of June 10, 2027, or the date of the 2027 annual meeting of stockholders. This transaction is a direct acquisition with a transaction price of $0.00 per share. Following this acquisition, Schmidt now owns 36,019 shares. The filing was made on Form 4, signed by Kathy Diep as Attorney-in-Fact, with a signature date of June 12, 2026.